Clinical profile of astemizole. A survey of 50 double-blind trials

Ann Allergy. 1987 Mar;58(3):184-8.

Abstract

From clinical-pharmacologic and clinical data involving over 2,800 patients, astemizole appears to be a very effective and well-tolerated antihistamine. It is superior to placebo and commonly used antihistamines for the relief of rhinitis, particularly rhinorrhea and sneezing. It has a pronounced effect on ocular itching and lacrimation in conjunctivitis and on pruritus and wheals in urticaria. This superiority is due to a very specific, almost complete and sustained histamine H1-blockade. The clinical data confirm the experimental data in relation to its lack of sedative effects.

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Astemizole
  • Benzimidazoles / therapeutic use*
  • Clinical Trials as Topic
  • Conjunctivitis, Allergic / drug therapy*
  • Double-Blind Method
  • Female
  • Histamine H1 Antagonists / therapeutic use*
  • Humans
  • Male
  • Rhinitis, Allergic, Perennial / drug therapy*
  • Rhinitis, Allergic, Seasonal / drug therapy*
  • Urticaria / drug therapy*

Substances

  • Benzimidazoles
  • Histamine H1 Antagonists
  • Astemizole